Liver Transplantation

New Approach Needed To Prevent Hepatitis B In Patients

Published in Vaccine Weekly, May 9th, 2001

Researchers in Italy report that a triple course of hepatitis B vaccination is not effective in preventing infection in patients who have undergone liver transplantation for hepatitis-B-related cirrhosis.

Gastroenterologist M. Angelico and colleagues at the University of Rome Tor Vergata reported their findings at the 36th annual meeting of the European Association for the Study of the Liver (EASL), held April 18-22, 2001, in Prague, Czech Republic. Their study is titled "Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis."

Angelico et al. wrote in their EASL conference abstract: ...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2001-05-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry